Form D · Biotechnology
Purigen Biosystems, Inc.
Pleasanton, CA · CIK 0001574680
Offering snapshot reported Apr 6, 2021 · SEC filing
- Reported sold
- $34.4M Offering amount: $34.4M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 22, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 6, 2021 | Initial | $34,444,759 | No comparison | 16 | SEC filing |
| Jun 4, 2018 | Amendment | $26,448,000 | $5,598,391vs Oct 24, 2017 | 28 | SEC filing |
| Oct 24, 2017 | Amendment | $20,849,609 | $7,837,753vs Mar 10, 2016 | 28 | SEC filing |
| Mar 10, 2016 | Initial | $13,011,856 | No comparison | 27 | SEC filing |
| Aug 1, 2014 | Initial | $200,000 | No comparison | 5 | SEC filing |
| Apr 19, 2013 | Initial | $830,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-394826
Source: Form D, filed Apr 6, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mira Chaurushiya, Ph.D. | Director |
| Bill W. Colston | Director |
| Bill W. Colston, Ph.D. | Director |
| Kevin Corcoran | Director |
| Amy Hiddessen | Director, Executive, Promoter |
| Mitchell Mutz | Director |
| Steve Reichenbach | Executive |
| Klint Rose | Executive, Promoter |
| Klint Rose, Ph.D. | Executive |
| Juan Santiago | Promoter |
| Barnett Saunders | Director, Executive |
| Barney E. Saunders,Ph.D. | Director, Executive |
| Andrew Schwab | Director |
| Joseph J. Victor | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5700 Stoneridge Dr., Ste. 100
Pleasanton, CA, 94588
Pleasanton, CA, 94588